Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

65

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Role of plasmin in metastatic tumors

Related Posts

Design of CoQ10 crops based on evolutionary history

Design of CoQ10 crops based on evolutionary history

87

Abnormal O-glycan sialylation in the mPFC contributes to depressive-like behaviors in male mice

Abnormal O-glycan sialylation in the mPFC contributes t...

30

Sensorimnemonic decisions: choosing memories versus sensory information

Sensorimnemonic decisions: choosing memories versus sen...

67